WASHINGTON — The FDA’s Office of Prescription Drug Promotion uses many methods to assess the validity of a potential medication’s print advertising, labels and other such materials for a particular medication before the agency can clear the materials for public marketing, an employee within the agency’s office that oversees that variable process said.

“FDA regulations require that prescription drug advertisements be fair and balanced, both in terms of the content and the presentation of the information,” Kathryn Aikin, PhD, research team lead at the FDA Office of Prescription Drug Promotion, told attendees of the Rising Leaders Conference on Healthcare Policy.